 LONDON and NEW YORK, Aug. 11, 2021 GLOBE NEWSWIRE -- MeiraGTx Holdings plc Nasdaq: MGTX, a vertically integrated, clinical stage gene therapy company, today announced financial results for the second quarter ended June 30, 2021 and provided an update on recent progress. 